```html

Xanthoma (Yellowish Skin Nodules)

What is Xanthoma (yellowish skin nodules)?

A xanthoma is a benign skin lesion that appears as a yellow‑orange, often slightly raised nodule or plaque. The colour comes from an accumulation of lipids (fat) within specialized immune cells called macrophages that settle in the skin’s dermis. Xanthomas are not cancerous, but they frequently signal an underlying metabolic or systemic disorder, especially disorders of lipid metabolism.

While most people think of xanthomas as purely cosmetic, they can be a valuable clue for clinicians to diagnose conditions such as high cholesterol, diabetes, or even certain liver diseases. Recognizing the pattern, location, and associated signs can lead to early treatment of potentially serious health problems.<sup>1</sup>

Common Causes

Below are the most frequent medical conditions and situations that can produce xanthomas. In many cases, more than one cause may coexist.

• Familial hypercholesterolemia (FH) – an inherited defect in LDL‑receptor function leading to very high LDL‑cholesterol levels.
• Familial combined hyperlipidemia – elevated LDL, VLDL, and triglycerides.
• Hypertriglyceridemia (type IV/V dyslipidemia) – especially when triglyceride levels exceed 500 mg/dL.
• Type IIa and IIb dyslipidemia – high LDL with or without high VLDL.
• Diabetes mellitus (type 2) – especially when poorly controlled, leading to secondary lipid abnormalities.
• Primary biliary cholangitis & other cholestatic liver diseases – cause impaired lipid clearance.
• Pompe disease and other lysosomal storage disorders – accumulate lipids in multiple tissues.
• Necrotizing granulomatous diseases (e.g., sarcoidosis) – can produce “xanthoma‑like” lesions.
• Drug‑induced lipid abnormalities – e.g., protease inhibitors, cyclosporine, beta‑blockers.
• Secondary causes – hypothyroidism, nephrotic syndrome, or severe malnutrition leading to altered lipid metabolism.

Each cause has a characteristic pattern of xanthoma distribution, which helps clinicians narrow the diagnosis.

Associated Symptoms

Xanthomas themselves are usually painless, but they often appear alongside other clinical findings that point to the underlying disorder.

• Skin findings – tendon xanthomas on Achilles tendon or hand extensor tendons, eruptive xanthomas on buttocks/upper arms, tuberous xanthomas on elbows/knees.
• Cardiovascular signs – early‑onset coronary artery disease, angina, or peripheral arterial disease in patients with familial hypercholesterolemia.
• Systemic symptoms – fatigue, weight loss, or abdominal pain in cholestatic liver disease.
• Eye changes – corneal arcus (a white‑gray ring around the cornea) often co‑exists with high cholesterol.
• Neurologic complaints – peripheral neuropathy in diabetes or certain storage diseases.
• Laboratory abnormalities – markedly elevated LDL, VLDL, triglycerides, or low HDL; abnormal liver function tests.

When to See a Doctor

Because xanthomas can herald serious metabolic disease, you should schedule an appointment promptly if you notice any of the following:

• New yellowish nodules or plaques that do not fade with pressure.
• Sudden increase in number or size of lesions.
• Family history of early‑onset heart attacks, stroke, or high cholesterol.
• Accompanying symptoms such as chest pain, shortness of breath, persistent abdominal pain, or unexplained weight loss.
• Any skin lesion that becomes painful, ulcerated, or infected.

Even if the nodules are asymptomatic, a medical evaluation is important to rule out hidden lipid disorders or systemic disease.

Diagnosis

Diagnosing xanthoma involves a combination of visual assessment, laboratory testing, and sometimes imaging or biopsy.

1. Clinical Examination

• Location (tendon, eruptive, tuberous, plane) helps differentiate the underlying lipid abnormality.
• Texture and size are documented; lesions are usually soft to firm, non‑fluctuant.

2. Blood Tests

• Lipid panel – total cholesterol, LDL‑C, HDL‑C, triglycerides.
• Secondary work‑up: fasting glucose/HbA1c, thyroid‑stimulating hormone (TSH), liver enzymes, renal function.
• Genetic testing for familial hypercholesterolemia (e.g., LDLR, APOB, PCSK9) if clinically indicated.

3. Imaging

• Ultrasound or MRI of tendons to confirm tendon xanthomas, especially before surgical removal.
• Cardiac stress testing or coronary CT angiography if cardiovascular risk is high.

4. Skin Biopsy (rarely needed)

If the appearance is atypical or malignancy cannot be excluded, a punch or excisional biopsy may be performed. Histology shows lipid‑laden foamy macrophages in the dermis, confirming a xanthoma.<sup>2</sup>

Treatment Options

Therapy focuses on two goals: eliminating the underlying cause and, when desired, removing the visible lesions.

1. Addressing the Root Cause

• Lipid‑lowering medications
  • Statins – first‑line for high LDL; reduce cardiovascular events.
  • Ezetimibe – added when statins alone are insufficient.
  • PCSK9 inhibitors (evolocumab, alirocumab) – highly effective for familial hypercholesterolemia.
  • Fibrates – target high triglycerides; useful for eruptive xanthomas.
  • Omega‑3 fatty acid ethyl esters – lower triglycerides.
• Management of secondary conditions
  • Optimizing glycemic control in diabetes (metformin, GLP‑1 agonists, SGLT2 inhibitors).
  • Treating hypothyroidism with levothyroxine.
  • Managing cholestatic liver disease with ursodeoxycholic acid or obeticholic acid.
• Lifestyle modifications (see Prevention Tips below).

2. Direct Treatment of Lesions

• Observation – many small xanthomas regress once lipid levels are normalized.
• Laser therapy – CO₂ or pulsed dye lasers can flatten superficial, plane xanthomas.
• Surgical excision – reserved for large, bothersome nodules, especially on weight‑bearing tendons.
• Cryotherapy or chemical peels – occasionally used for eruptive lesions.

Patients should discuss cosmetic options with a dermatologist experienced in vascular/dermal laser procedures.

Prevention Tips

While you cannot prevent genetic lipid disorders, you can lower the risk of developing xanthomas by controlling modifiable factors.

• Adopt a heart‑healthy diet – emphasize fruits, vegetables, whole grains, legumes, nuts, and fatty fish; limit saturated fat, trans fat, and cholesterol.
• Maintain a healthy weight – BMI < 25 kg/m² reduces triglyceride and LDL elevations.
• Exercise regularly – at least 150 minutes of moderate‑intensity aerobic activity per week improves HDL and lowers LDL.
• Avoid tobacco and limit alcohol – both worsen lipid profiles and increase cardiovascular risk.
• Screen family members – early lipid testing for first‑degree relatives of patients with FH can enable pre‑emptive treatment.
• Take prescribed medications consistently – never stop statins or other lipid‑lowering drugs without a clinician’s guidance.
• Monitor labs – repeat lipid panels every 3–12 months, depending on risk level.
• Control comorbidities – keep blood pressure, blood sugar, and thyroid function within target ranges.

Emergency Warning Signs

Key Take‑aways

Xanthomas are more than a cosmetic issue; they are visual markers of lipid metabolism disturbances or systemic disease. Early detection, thorough evaluation, and aggressive management of the underlying cause can prevent serious complications such as premature heart disease, pancreatitis, or liver damage. If you notice yellowish nodules on your skin, especially with a family history of high cholesterol or heart problems, schedule a medical appointment promptly.

References

1. Mayo Clinic. Xanthomas: Causes, Symptoms, and Treatments. Updated 2023. https://www.mayoclinic.org.
2. American Academy of Dermatology. Clinical Diagnosis of Xanthoma. 2022. https://www.aad.org.
3. National Lipid Association. Guidelines for the Management of Familial Hypercholesterolemia. 2021.
4. World Health Organization. Non‑communicable Diseases: Cardiovascular Disease Fact Sheet. 2022.
5. Cleveland Clinic. Hypertriglyceridemia and Risk of Pancreatitis. 2023.

```